634 related articles for article (PubMed ID: 34509090)
1. Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials.
Bartoli F; Cavaleri D; Bachi B; Moretti F; Riboldi I; Crocamo C; Carrà G
J Psychiatr Res; 2021 Nov; 143():230-238. PubMed ID: 34509090
[TBL] [Abstract][Full Text] [Related]
2. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of adjunctive modafinil/armodafinil in bipolar depression: A meta-analysis of randomized controlled trials.
Nunez NA; Singh B; Romo-Nava F; Joseph B; Veldic M; Cuellar-Barboza A; Cabello Arreola A; Vande Voort JL; Croarkin P; Moore KM; Biernacka J; McElroy SL; Frye MA
Bipolar Disord; 2020 Mar; 22(2):109-120. PubMed ID: 31643130
[TBL] [Abstract][Full Text] [Related]
4. Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials.
Chen AT; Malmstrom T; Nasrallah HA
J Affect Disord; 2018 Jan; 226():245-250. PubMed ID: 29017068
[TBL] [Abstract][Full Text] [Related]
5. Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials.
Bartoli F; Crocamo C; Clerici M; Carrà G
Br J Psychiatry; 2017 Jan; 210(1):10-15. PubMed ID: 27856422
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
[TBL] [Abstract][Full Text] [Related]
7. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.
Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE
J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole alone or in combination for acute mania.
Brown R; Taylor MJ; Geddes J
Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
[TBL] [Abstract][Full Text] [Related]
10. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis.
Bartoli F; Clerici M; Di Brita C; Riboldi I; Crocamo C; Carrà G
J Psychopharmacol; 2018 Apr; 32(4):416-422. PubMed ID: 29338576
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials.
Kishi T; Miyake N; Okuya M; Sakuma K; Iwata N
Psychopharmacology (Berl); 2020 Nov; 237(11):3481-3487. PubMed ID: 32767039
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
Calabrese JR; Ketter TA; Youakim JM; Tiller JM; Yang R; Frye MA
J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
[TBL] [Abstract][Full Text] [Related]
13. Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults.
McCloud TL; Caddy C; Jochim J; Rendell JM; Diamond PR; Shuttleworth C; Brett D; Amit BH; McShane R; Hamadi L; Hawton K; Cipriani A
Cochrane Database Syst Rev; 2015 Sep; (9):CD011611. PubMed ID: 26415966
[TBL] [Abstract][Full Text] [Related]
14. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
15. Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis.
Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
Can J Psychiatry; 2021 Mar; 66(3):274-288. PubMed ID: 33174452
[TBL] [Abstract][Full Text] [Related]
16. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
Muralidharan K; Ali M; Silveira LE; Bond DJ; Fountoulakis KN; Lam RW; Yatham LN
J Affect Disord; 2013 Sep; 150(2):408-14. PubMed ID: 23735211
[TBL] [Abstract][Full Text] [Related]
18. The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
Pittas S; Theodoridis X; Haidich AB; Bozikas PV; Papazisis G
Psychopharmacology (Berl); 2021 Jul; 238(7):1729-1736. PubMed ID: 33641060
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of armodafinil for the treatment of bipolar depression.
Niemegeers P; Maudens KE; Morrens M; Patteet L; Joos L; Neels H; Sabbe BG
Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1189-97. PubMed ID: 22803602
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
Sarris J; Mischoulon D; Schweitzer I
J Clin Psychiatry; 2012 Jan; 73(1):81-6. PubMed ID: 21903025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]